Folisurge 75IU Injection

Folisurge 75IU Injection contains follitropin alfa as the active ingredient. It is used in assisted reproductive technologies (ART) to treat infertility in men and women. Follitropin alfa is a synthetic form of follicle-stimulating hormone (FSH) that stimulates the development of eggs in women and sperm in men. Infertility is defined as the inability to conceive after one year of regular unprotected intercourse.

The medication stimulates the development of multiple follicles in women and enhances sperm production in men, enabling precise timing for optimal ovulation. It has demonstrated efficacy with a generally safe profile and can increase pregnancy rates while shortening treatment duration.

Folisurge 75IU Injection is contraindicated in individuals with known hypersensitivity or allergic reaction to follitropin alfa or any component of the formulation. Although rare, allergic reactions may occur and require immediate medical attention.

Patients with ovarian cysts or tumours should not use Folisurge 75IU Injection, as the medication may worsen these conditions. It should not be used in patients with uncontrolled hypothyroidism or adrenal dysfunction. Uncontrolled hypothyroidism is a state in which thyroid hormone levels remain inadequately regulated, causing persistent symptoms and potential complications.

Individuals with abnormalities or blockages in the reproductive tract that impede egg or sperm transport may not benefit from this medication. It is not generally recommended for paediatric or elderly populations.

Folisurge 75IU injection is used in the following: Assisted Reproductive Technologies (ART) Ovulation Induction Treatment of Male Infertility Hypogonadism

Folisurge 75IU injection, a recombinant follicle-stimulating hormone (FSH), exerts its mechanism of action by binding to the FSH receptors on the ovarian granulosa cells in females or Sertoli cells in males. This binding stimulates the growth and development of ovarian follicles in women, leading to the maturation of eggs, and in men, it promotes the production and maturation of sperm. By mimicking the natural FSH, this medication helps regulate reproductive processes, making it valuable in infertility treatments and other related conditions.

Folisurge 75IU injection is administered through subcutaneous injection. Patients are typically provided with clear instructions and guidance on how to administer the injections safely and effectively during their treatment period.

Folisurge 75IU injection causes some side effects like all medications, although not everyone will experience them. Serious: Severe Skin ReactionsOvarian Hyperstimulation Syndrome (OHSS) Allergic Reactions Ectopic Pregnancy Blood Clots Common: Injection Site Reactions Abdominal Discomfort Nausea Headache Fatigue

Patients should be mindful of potential risks of Folisurge 75IU injection, including Ovarian Hyperstimulation Syndrome (OHSS), multiple pregnancies, and ectopic pregnancy. Women with asthma or respiratory conditions should use it with care, and patients with pre-existing heart conditions should be closely monitored. Fertility treatments can have emotional effects, necessitating adequate psychological support. Patients must inform their healthcare providers of their complete medical history, and proper handling, dosage adjustment, and monitoring are essential. Regular ultrasound examinations and adherence to prescribed dosages are crucial, and patients should be attentive to potential risks and seek counseling and support during treatment. Other considerations include travel precautions, drug disposal, and informed consent to ensure the safest and most effective use of the medication.